australia clinical guidance

Ectopic pregnancy and miscarriage

A detailed Australian summary of ectopic pregnancy and miscarriage, with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

In any reproductive-age person with pain or bleeding, establish pregnancy status, last menstrual period, risk factors, observations and haemodynamic stability. Use quantitative hCG and transvaginal ultrasound within the RANZCOG early-pregnancy pathway, recognizing that one result may not locate viability safely. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:RANZCOG C-Gyn 38

The Bottom Line

  • In any reproductive-age person with pain or bleeding, establish pregnancy status, last menstrual period, risk factors, observations and haemodynamic stability.
  • Use quantitative hCG and transvaginal ultrasound within the RANZCOG early-pregnancy pathway, recognizing that one result may not locate viability safely.
  • Anti-D eligibility has changed over time and must be checked against the current Australian gestation and management criteria.
  • For miscarriage, discuss expectant, medical and surgical options through clinical stability, gestation, bleeding, infection risk and patient preference.
sources for this section:RANZCOG C-Gyn 38

Practical clinical workflow

1

Topic-specific assessment action

In any reproductive-age person with pain or bleeding, establish pregnancy status, last menstrual period, risk factors, observations and haemodynamic stability.
2

Topic-specific diagnostic action

For miscarriage, discuss expectant, medical and surgical options through clinical stability, gestation, bleeding, infection risk and patient preference.
3

Topic-specific management action

Provide RhD immunoglobulin only under the current Australian indication and arrange emotional support, result follow-up and future-pregnancy advice.
4

Topic-specific follow-through

Offer pathology or genetic testing only in guideline-defined contexts and explain what a result can and cannot establish.
sources for this section:RANZCOG C-Gyn 38

Safety boundaries and escalation

  • Shock, syncope, shoulder-tip pain, peritonism, heavy bleeding or significant pain with pregnancy of unknown location requires immediate emergency assessment.
  • Provide written warning signs and a direct contact route because bleeding and pain can change after initial expectant management.
sources for this section:RANZCOG C-Gyn 38

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:RANZCOG C-Gyn 38

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:RANZCOG C-Gyn 38

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Royal Australian and New Zealand College of Obstetricians and GynaecologistsMiscarriage, Recurrent Miscarriage and Ectopic Pregnancy (C-Gyn 38)C-Gyn 38 路 2025 clinical guidance 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Found a source update or regional discrepancy? Tell the iatroX editorial team.